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            IL-6 is produced by APCs such as macrophages, 
dendritic cells, and B cells, but also by nonhema-
topoietic cells (e.g., epithelial and endothelial 
cells, astrocytes, and fi  broblasts) in response to 
external stimuli such as TNF-    , IL-1    , platelet-
derived growth factor, or bacterial and fungal 
components. It binds to a receptor complex con-
sisting of the specifi  c IL-6R     and the gp130 sig-
nal transducing unit that activates the transcription 
factor STAT3, among other signaling molecules. 
IL-6 is a pleiotropic cytokine that plays an impor-
tant role in acute-phase protein synthesis, bone 
metabolism, central nervous system function, 
growth and drug response of tumors, and the im-
mune response (for reviews see references   1, 2  ). 
Regarding its function in the immune system, 
IL-6 is now thought of as an important link be-
tween innate and adaptive immunity, mediating 
several aspects of B and T cell responses (  3  ). 
  The role of IL-6 in CD4  +   T cell function 
is multifaceted. IL-6 infl  uences T cell eff  ector 
functions by promoting Th2 cell diff  erentiation 
through up-regulation of NFATc2 and c-maf 
(  4, 5  ). It also blocks IFN-     signaling through in-
creased expression of silencer of cytokine signal-
ing 1, thereby inhibiting Th1 cell diff  erentiation 
(  5  ). In the presence of TGF-    , IL-6 promotes 
Th17 cell diff  erentiation through STAT3-me-
diated up-regulation of the transcription factor 
retinoic acid receptor-related orphan receptor     t 
(  6  –  10  ). Although some of the molecular mech-
anisms used by IL-6 to mediate these diff  erent 
responses are known, it is still unclear how these 
various eff  ects on CD4  +   T cells are orchestrated. 
  IL-6 was initially characterized as a factor that 
enhances antibody production in a B cell line 
(  11  ), and overexpression of IL-6 in mice causes 
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enhances virus-specifi  c antibody production, and importantly, this effect is dependent on 
IL-21. Thus, IL-6 promotes antibody production by promoting the B cell helper capabilities 
of CD4  +   T cells through increased IL-21 production. IL-6 could therefore be a potential 
coadjuvant to enhance humoral immunity. 
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when using a twofold threshold on the probe set intensity ra-
tio, IL-6 treated to untreated (  Fig. 1 B  ; and Fig. S1 and Table 
S1, available at http://www.jem.org/cgi/content/full/jem
.20081571/DC1). The microarray results were validated by 
real-time RT-PCR of several genes positively or negatively 
aff  ected by the IL-6 treatment (Fig. S2). 
  Among the 132 genes whose expression was aff  ected by 
IL-6, the cytokine IL-21 was especially remarkable, with a 
  >  200-fold induction in CD4  +   T cells activated in the presence 
of IL-6. The induction of IL-21 by IL-6 was confi  rmed by 
real-time RT-PCR using RNA from CD4  +   T cells activated 
for 16 h (  Fig. 1 C  ). Similar results were obtained by ELISA, 
where IL-21 production could only be detected in the pres-
ence of IL-6 (  Fig. 1 D  ). Although IL-6 has been shown to in-
duce the expression of IL-4 and IL-17 (  7, 8, 10, 22  ), their 
expression was not increased by IL-6 stimulation early during 
activation. These results also confi  rm a recent study showing 
that induction of IL-21 by IL-6 is independent of TGF-     stim-
ulation and Th17 cell diff  erentiation (  23  ). Moreover, among 
known cytokines IL-21 is the most potently induced one by 
IL-6 early during the activation of CD4  +   T cells, as indicated 
by its high up-regulation, especially when compared with other 
soluble factors (Table S1). 
  IL-6 is required for IL-21 expression in CD4 T cells 
upon TCR stimulation 
  Given the high induction of IL-21 by IL-6, we examined 
whether other cytokines have a similar eff  ect. CD4  +   T cells 
were activated in the presence of IL-4, IL-12, or IFN-    , but 
none of those cytokines were able to promote IL-21 produc-
tion (  Fig. 2 A  ).   Neither growth and survival factors such as 
IL-2 and IL-7 (  Fig. 2 A   and not depicted) nor other proinfl  am-
matory cytokines such as TNF-     and IL-1 were able to up-regu-
late IL-21 production (  Fig. 2 A   and not depicted). IL-11, another 
cytokine that signals through gp130 (  1  ), also failed to promote 
IL-21 production (Fig. S3, available at http://www.jem.org/
cgi/content/full/jem.20081571/DC1). Moreover, IL-6 is a very 
effi   cient inducer of IL-21 expression, as a dose  –  response analysis 
revealed that IL-6 levels as low as 0.3  –  0.8 ng/ml were able to 
readily induce measurable IL-21 production (  Fig. 2 B  ). 
  To determine whether IL-6 was required for IL-21 produc-
tion by CD4  +   T cells, spleen cells from wild-type or IL-6      /      
mice were treated with LPS, and the conditioned media were 
added to CD4  +   T cells activated with anti-CD3 and anti-CD28 
mAbs. Only CD4  +   T cells activated in the presence of the LPS-
conditioned media from wild-type splenocytes expressed IL-21, 
whereas this expression was abrogated in the presence of a neu-
tralizing anti  –  IL-6 mAb (  Fig. 2 C  ). In addition, conditioned 
media from IL-6      /      splenocytes stimulated with LPS did not 
promote IL-21 expression (  Fig. 2 C  ). As a control, LPS alone 
added to activated CD4  +   T cells did not induce IL-21 expres-
sion (  Fig. 2 C  ). Thus, APC-derived IL-6 is required for IL-21 
production by CD4  +   T cells upon activation in vitro. To show 
that IL-6 is required for IL-21 expression in vivo, IL-6      /      and 
wild-type mice were immunized with OVA, and CD4  +   T 
cells were analyzed for IL-21 production by ELISPOT analysis. 
plasmocytosis, suggesting that IL-6 can promote the diff  erentia-
tion of B cells into plasma cells (  12  ). Likewise, IL-6  –  defi  cient 
mice show reduced antigen-specifi  c IgG1, IgG2a, and IgG3 
levels upon immunization with a T cell  –  dependent antigen, al-
though IgM levels were not aff  ected (  13  ). Further evidence for 
a role of IL-6 in IgG production has come from experiments 
using a transgenic mouse expressing a truncated form of gp130. 
These mice are unable to activate STAT3 upon IL-6 exposure 
and show reduced levels of most antibody isotypes after immu-
nization with a T-dependent antigen (  14  ). However, expression 
of the transgene is not restricted to B cells, leaving open the 
possibility that other cells may require a functional gp130 
receptor. Likewise, B cell  –  specifi  c deletion of STAT3 results in 
impaired plasma cell diff  erentiation and diminished antibody 
responses (  15  ), but this transcription factor is also activated by 
other cytokines. 
  The cytokine IL-21 has been shown to play a major role in 
antibody production by promoting the diff  erentiation of B 
cells into plasma cells both in mice and humans (  16, 17  ). Ac-
cordingly, IL-21 promotes the production of IgG1, IgG2a, and 
IgG3, but it has an inhibitory eff  ect on IgE production (  18  ). 
The inhibition of IgE is mediated by IL-21  –  induced up-regu-
lation of Id2 that negatively regulates class switching to IgE 
(  19  ). Similar to IL-6, IL-21 activates predominantly STAT3, 
but through binding to its specifi  c receptor and the common      
chain signal transducing unit that it shares with other members 
of the IL-2 family of cytokines (  20  ). In B cells, IL-21  –  induced 
STAT3 activation down-regulates B cell lymphoma 6 and up-
regulates expression of B lymphocyte  –  induced maturation 
protein 1, thereby promoting plasma cell diff  erentiation (  21  ). 
  In this report, we identify IL-21 as the only cytokine that 
is specifi  cally induced in CD4  +   T cells by IL-6 early upon an-
tigen stimulation. IL-6 is necessary to mediate IL-21 produc-
tion in naive CD4  +   T cells during antigen stimulation. 
Furthermore, we show that IL-6 promotes antibody produc-
tion in B cells indirectly by up-regulation of IL-21 expression 
in CD4  +   T cells and that this IL-21 then acts on B cells. 
    RESULTS AND DISCUSSION   
  Regulation of early gene expression by IL-6 
during the activation of CD4  +   T cells 
  IL-6 has been associated with diff  erent aspects of T cell acti-
vation, diff   erentiation, and survival (  2  ). However, little is 
known about the changes in gene expression induced by IL-6 
stimulation early during T cell activation. To further charac-
terize early eff  ects of IL-6 on CD4  +   T cells, we performed 
microarray analysis. Sorted CD4  +   NK1.1        T cells were acti-
vated with anti-CD3 and anti-CD28 mAbs in the absence or 
presence of IL-6 for 16 h. For each condition, three indepen-
dent preparations of RNA were used for hybridization of 
gene arrays. For analysis of microarray data, we explored the 
use of the 1% contour on the joint distribution of fold change 
and p-value derived from sample label permutations (  Fig. 1 A  ), 
which resulted in signifi  cance at P = 0.1, as well as identifi  ca-
tion of 343 genes, with a false discovery rate of 13%.   132 dif-
ferentially regulated genes (190 probe sets) were found JEM VOL. 206, January 19, 2009  71
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tion in vitro and in vivo  .   Although a recent paper reported that 
IL-21 can induce its own expression through STAT3 (  24  ), our 
results indicate that the initial IL-21 expression in CD4  +   T cells 
is mediated by IL-6. 
The number of IL-21  –  producing CD4  +   T cells was severely 
impaired in IL-6      /      compared with wild-type mice (  Fig. 2 D  ). 
Collectively, these results demonstrate that IL-6 is required for 
the production of IL-21 by CD4  +   T cells upon antigen stimula-
    Figure 1.         Effects of IL-6 on the gene expression profi  le of CD4  +   T cells early during activation.   (A) FACS-sorted CD4  +   T cells were activated with 
anti-CD3 and anti-CD28 in the absence or presence of IL-6 for 16 h. The gene expression profi  le from total RNA was examined by Affymetrix GeneChip 
analysis. In the volcano plot, open circles represent probe sets for which expression is changed more than twofold up or down after IL-6 treatment, 
whereas dots represent all other probe sets. The number of genes exceeding the threshold was the largest among the 10 datasets obtained by permuta-
tion of sample labels, yielding statistical signifi  cance of differential expression at P = 0.1 (the minimum value) and a false discovery rate   <  19% (the mini-
mum being 10%). The blue line encloses 99% of the probe sets under the null hypothesis, obtained by permutation of sample labels. The IL-21 gene is 
marked with an arrow. (B) Heat maps representing the relative expression of genes among IL-6  –  treated and control samples. Genes were sorted within 
each group based on their fold change (top, highest fold induction; bottom, highest fold down-regulation). Expression statistics for each gene were cen-
tered, scaled, and mapped to a color scale. Red represents relatively low expression, whereas green represents relatively high expression. (C) Cells were 
purifi  ed and activated as in A, and IL-21 expression was measured by quantitative real-time RT-PCR. The means   ±   SEM of three experiments are shown. 
(D) CD4  +   T cells were activated with anti-CD3 and anti-CD28 mAbs in the absence or presence of IL-6 for the indicated periods of time. Cell-culture su-
pernatants were analyzed for IL-21 production by ELISA. The means   ±   SEM of four experiments are shown.     72 IL-6  –  INDUCED IL-21 PROMOTES ANTIBODY PRODUCTION   | Dienz et al. 
    Figure 2.         IL-6 is suffi  cient and necessary to induce IL-21 expression during the activation of naive and memory CD4  +   T cells.   (A and B) FACS-
sorted CD4  +   T cells were activated with anti-CD3 and anti-CD28 mAbs in the absence or presence of the indicated cytokines (A) or the indicated IL-6 
concentrations (B). After 3 d, cell-culture supernatants were analyzed for IL-21 production by ELISA. The means   ±   SEM of three (A) or four (B) ex-
periments are shown. (C) FACS-purifi  ed CD4  +   T cells were activated with anti-CD3 and anti-CD28 mAbs in the presence of medium alone, LPS, condi-
tioned media (CM) from LPS-stimulated mouse splenocytes, CM plus 10   μ  g/ml of a neutralizing anti  –  IL-6 (    IL-6) mAb, or CM from LPS-stimulated 
IL-6     /     splenocytes. IL-21 expression was measured by quantitative real-time RT-PCR. One representative experiment out of two is shown (error bars 
represent SD). (D) C57BL/6 and IL-6     /     mice were immunized s.c. with 200   μ  g OVA in CFA. CD4  +   T cells prepared from spleens and lymph nodes were 
analyzed 6 d later for the frequency of IL-21  –  producing cells by ELISPOT. The means   ±   SD of three immunizations are shown (P   <   0.05). (E) FACS-puri-
fi  ed CD4  +   CD25       NK1.1       CD44 low   naive cells were activated with anti-CD3 and anti-CD28 mAbs in the absence or presence of IL-6 for the indicated 
periods of time. IL-21 expression was measured by quantitative real-time RT-PCR. One representative experiment out of two is shown (error bars repre-
sent SD). (F) CD4  +   T cells were isolated from AND TCR transgenic mice, and activated with 5   μ  M cyt c peptide and APCs in the absence or presence of 
IL-6 for the indicated periods of time. IL-21 production was examined by ELISA. One representative experiment out of two is shown (error bars represent 
SD of a triplicate determination). (G) FACS-purifi  ed CD4  +   CD25       NK1.1       CD44 high   memory cells were activated with anti-CD3 and anti-CD28 mAbs in 
the absence or presence of IL-6 for 24 h. Cytokine expression was measured by quantitative real-time RT-PCR. Values are presented as fold induction 
over naive CD4  +   T cells activated for 24 h. One representative experiment out of two is shown.     JEM VOL. 206, January 19, 2009  73
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IL-21 expression was similar to other eff  ector cytokines up-
regulated early in memory CD4  +   T cells, sorted CD4  +   CD44  high   
T cells were stimulated with anti-CD3 and anti-CD28 mAbs 
in the absence or presence of IL-6. As expected, memory 
CD4  +   T cells expressed relatively high levels of IFN-     and 
IL-4 regardless of the presence of IL-6 (  Fig. 2 G  ). However, 
similar to naive CD4  +   T cells, memory cells did not produce 
IL-21 in the absence of IL-6 but did have high levels of ex-
pression when IL-6 was present (  Fig. 2 G  ). Thus, production 
of IL-21 by naive and memory CD4  +   T cells upon antigen 
stimulation requires the presence IL-6. 
  Induction of antibody production by IL-6 requires 
up-regulation of IL-21 expression in CD4  +   T cells 
  Both IL-6 and IL-21 have been shown to promote antibody 
production by B cells. Several studies demonstrated a direct eff  ect 
of IL-21 on plasma cell diff  erentiation through up-regulation of 
  IL-21 has been shown to be produced by diff  erentiated 
Th2 and Th17 eff  ector CD4  +   T cells upon restimulation as 
well as by NKT cells (  25  –  29  ). To further demonstrate the di-
rect eff  ect of IL-6 on IL-21 production by naive CD4  +   T cells, 
we activated sorted CD4  +   CD44  low   NK1.1        T cells in the 
presence or absence of IL-6. IL-21 expression was essentially 
undetectable in purifi  ed naive CD4  +   T cells activated in the 
absence of IL-6 even after 3 d of stimulation (  Fig. 2 E  ). In 
contrast, high IL-21 expression could be detected in activated 
naive CD4  +   T cells treated with IL-6 as soon as 24 h after ini-
tial stimulation (  Fig. 2 E  ). Similarly, naive CD4  +   T cells from 
AND TCR transgenic mice (recognizing pigeon cytochrome 
c [cyt c]) produce IL-21 only in the presence of IL-6 upon 
stimulation with cyt c peptide and APCs (  Fig. 2 F  ). 
  Memory CD4  +   T cells are known for their ability to pro-
duce high amounts of eff  ector cytokines such as IFN-     and 
IL-4 rapidly after antigen stimulation (  30  ). To test whether 
    Figure 3.         IL-6 requires IL-21 expression in CD4  +   T cells to induce IgG1 production.   (A) Total splenocytes from wild-type and IL-6     /     mice 
were stimulated with anti-CD3 mAb for 7 d. IgG1 levels in the cell supernatant were measured by ELISA. Results are representative of three experi-
ments performed in triplicate. (B) B220  + CD19 +   B cells and CD4  +   T cells from the spleens of C57BL/6 mice were analyzed for IL-6R     and IL-21R expres-
sion (bold-line histograms) by fl  ow cytometry. Shaded histograms are control-stained cells. Representative profi  les of one mouse out of fi  ve analyzed 
are shown. (C) Total splenocytes of IL-6     /     mice were activated with anti-CD3 mAb and 100 ng/ml IL-6 or 100 ng/ml IL-21 where indicated. After 7 d, 
IgG1 levels in the supernatant were determined by ELISA. (D) CD4  +   T cells from IL-21     /     mice or wild-type littermates were activated with anti-CD3 
mAb in the presence of B cells from IL-6     /     mice and the indicated cytokines. After 7 d, IgG1 levels in the supernatant were determined by ELISA. 
(E) CD4  +   T cells from wild-type mice were activated with anti-CD3 mAb in the presence of B cells from IL-21R     /     mice or wild-type littermates and 
the indicated cytokines. After 7 d, IgG1 levels in the supernatant were determined by ELISA. The means   ±   SEM of a triplicate determination from one 
representative experiment out of three performed are shown in A and C  –  E.     74 IL-6  –  INDUCED IL-21 PROMOTES ANTIBODY PRODUCTION   | Dienz et al. 
IL-6      /      mice, because IL-6 is known to be also produced by 
B cells. In the absence of IL-6, IgG1 levels were practically 
undetectable (  Fig. 3 D  ). IL-6 strongly increased IgG1 pro-
duction when B cells were cultured together with CD4  +   T 
cells from wild-type mice but failed to induce IgG1 in the 
presence of IL-21      /      CD4  +   T cells (  Fig. 3 D  ). Thus, the ef-
fect of IL-6 on antibody production appears to be dependent 
on IL-21 produced by CD4  +   T cells. Addition of exogenous 
IL-21 could compensate for IL-21 defi  ciency, indicating 
that IL-21      /      CD4  +   T cells are functional despite their lack of 
IL-21 production (  Fig. 3 D  ). 
  In addition to its eff  ects on B cells, IL-21 has been shown 
to promote Th2 cell diff  erentiation by inhibiting Th1 cell 
diff  erentiation (  25  ). It can also induce Th17 cell diff  erentia-
tion when TGF-     is present (  27  –  29  ). To exclude that IL-6  –
  induced IL-21 promoted antibody production through its 
eff  ect on the diff  erentiation of CD4  +   T cells rather than act-
ing directly on B cells, we activated wild-type CD4  +   T cells 
with anti-CD3 mAb and co-cultured them in the presence of 
B cells from wild-type and IL-21R      /      mice. IL-6 augmented 
IgG1 production in wild-type B cells compared with the me-
dium control (  Fig. 3 E  ). In contrast, B cells that were defi  -
cient for IL-21R did not produce IgG1 when stimulated with 
IL-6 despite co-cultured CD4  +   T cells that were capable of re-
ceiving IL-21 signals (  Fig. 3 E  ). Accordingly, IL-21 promoted 
the transcription factor B lymphocyte  –  induced maturation 
protein 1 (  16, 17, 21  ). Although in vitro experiments using 
T  –  B cell co-culture and in vivo studies indicate that IL-6 is 
required for antibody production (  13  ), the molecular mecha-
nism remains unknown, and it is unclear whether this is a di-
rect eff  ect on B cells. Because IL-6 promotes IL-21 production 
by CD4  +   T cells, it was possible that these two pathways are 
closely linked to provide T cell help to B cells. The analysis 
of antibody production in vitro with wild-type or IL-6      /      
total spleen cells activated with anti-CD3 mAb confi  rmed 
the contribution of IL-6 to IgG1 production (  Fig. 3 A  ).   
However, analysis of IL-6R     cell-surface expression showed 
that resting splenic B cells had almost undetectable levels, 
whereas it was present on a substantial fraction of CD4  +   T 
cells (  Fig. 3 B  ). In contrast, IL-21R expression could be de-
tected on B cells as well as CD4  +   T cells, in accordance with 
a previous paper (  20  ). In addition, IL-21 promoted IgG1 
production in total splenocytes from IL-6      /      mice activated 
with anti-CD3 mAb, similar to IL-6 (  Fig. 3 C  ). Collectively, 
these results suggest that IL-6 mediates antibody production 
by inducing IL-21 expression in CD4  +   T cells. To test for 
this possibility, we established a co-culture of CD4  +   T cells 
activated with anti-CD3 mAb and B cells in the presence of 
exogenous IL-6. CD4  +   T cells were isolated from wild-type 
and IL-21      /      mice, whereas B cells were obtained from 
    Figure 4.         IL-6 enhances antibody responses to inactive infl  uenza virus immunization through IL-21.   (A) Wild-type C57BL/6 mice were injected 
s.c. with 10  8   egg infectious units of inactive PR8 virus alone or together with IL-6. After 30 d, serum was harvested and infl  uenza-specifi  c IgM and IgG1 
levels were determined by ELISA. (B) IL-21     /     mice and wild-type littermates were treated as in A, and infl  uenza-specifi  c IgM and IgG1 levels were deter-
mined by ELISA. Experiments were performed twice with fi  ve mice per group. Error bars indicate SD.     JEM VOL. 206, January 19, 2009  75
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signals to B cells. In contrast, the presence of IL-6 during im-
munization substantially enhanced the levels of infl  uenza-
specifi  c IgG1 (  Fig. 4 A  ).   Thus, IL-6 enhances the in vivo 
antibody response. 
  To determine whether the eff  ect of IL-6 on in vivo antiviral 
antibody response is also dependent on IL-21, we immunized 
wild-type and IL-21      /      mice with inactive infl  uenza virus in 
the presence or absence of IL-6. Infl  uenza-specifi  c IgM levels 
were comparable in IL-21      /      and wild-type mice (  Fig. 4 B  ), in 
agreement with previous studies showing independence of IgM 
from IL-21 (  18  ). In contrast, IL-6 promoted the production of 
IgG1 in wild-type mice, but it had no eff  ect in IL-21      /      mice 
(  Fig. 4 B  ). Collectively, these results show that administration of 
IL-6 enhances antibody response, but this eff  ect is dependent 
on endogenous IL-21 production. 
  Role of IL-21 and IL-6 in antibody response 
to infl  uenza infection 
  Despite the established role of IL-21 in generation of plasma 
cells and antibody production, it remains unknown whether 
IL-21 plays a role in antibody response during infl  uenza in-
fection or any other viral infection. We therefore examined 
IgG1 production only when IL-21R was present on B cells 
but not in IL-21R      /      B cells, suggesting that IL-21 in-
duced by IL-6 acted directly on B cells to increase IgG1 levels 
(  Fig. 3 E  ). These results show that IL-6 can promote antibody 
production by inducing IL-21 expression in CD4  +   T cells, 
and IL-21 subsequently acts on B cells. 
  Administration of IL-6 during infl  uenza immunization 
promotes specifi  c IgG production through IL-21 
  The indirect eff  ect of IL-6 on antibody production through 
IL-21 generated by CD4  +   T cells suggested that IL-6 could be 
a potent enhancer of the humoral immune response, because 
small amounts of IL-6 could result in an increased and pro-
longed production of IL-21, which would increase antibody 
production by B cells. We therefore investigated whether ad-
ministration of IL-6 during viral immunization could boost 
the antiviral specifi  c antibody response. We immunized wild-
type mice with inactive PR8 infl  uenza virus (in the absence of 
adjuvant) in combination with IL-6 or PBS, and analyzed vi-
rus-specifi  c antibody production. Infl  uenza-specifi  c IgM se-
rum levels were not aff  ected by the administration of IL-6 
(  Fig. 4 A  ), indicating that IL-6 did not provide overall survival 
    Figure 5.         Role of IL-21 and IL-6 in infl  uenza virus infection.   (A) Wild-type and IL-21     /     mice were infected i.n. with a sublethal dose (0.1 LD  50 )  of 
active PR8 virus, and after 2 wk, infl  uenza-specifi  c IgG1 and IgG2c levels in serum were determined by ELISA. (B  –  D) Wild-type and IL-6     /     mice  were 
infected i.n. with a sublethal dose (0.05 LD  50  ) of active PR8 virus. Animals were monitored daily, and the time to death was recorded as the day after in-
fection. Kaplan-Meier survival curves were generated using Prism 4.03 software (GraphPad Software, Inc.), and the log-rank test was used to determine 
the signifi  cance of differences between the strains (B). Weight was also measured daily in the surviving mice. The percentage of the initial weight is 
shown (C). Serum levels of virus-specifi  c IgG1 were determined in the surviving mice (six out of six for wild-type mice and two out of six for IL-6     /     mice) 
14 d after infection (D). Data represent groups of fi  ve (A) or six (B  –  D) mice from one experiment out of two performed. Error bars indicate SD.     76 IL-6  –  INDUCED IL-21 PROMOTES ANTIBODY PRODUCTION   | Dienz et al. 
  MATERIALS AND METHODS 
  Mice 
  B10.BR and C57BL/6J mice (The Jackson Laboratory) were housed under 
sterile conditions at the animal care facility at the University of Vermont 
and used for experiments between 8 and 14 wk of age. IL-21 gene  –  defi  cient 
mice were obtained from the Mutant Mouse Regional Resource Center at 
the University of California, Davis, and were backcrossed to C57BL/6J. 
TCR transgenic AND mice specifi  c for pigeon cyt c, as well as IL-6 and 
IL-21R gene  –  defi  cient mice, as previously described (  18, 33, 34  ). Immuni-
zations were performed with UV-inactivated A/PR/8/34 (PR8) infl  uenza 
A virus (H1N1) injected s.c. together with 500 ng recombinant IL-6 (R  &  D 
Systems), as indicated in the fi  gures. For live infections, mice were inocu-
lated intranasally (i.n.) during light isofl  urane anesthesia with 0.05 or 0.1 
LD  50   (2.5 or 5   ×   10  3   egg infectious units/ml) of PR8 virus in 100   μ  l PBS. 
Procedures that involved mice were approved by the Institutional Animal 
Care and Use Committees from the University of Vermont and the 
Trudeau Institute. 
  Cell preparation and activation 
  CD4  +   T cells from lymph nodes and spleens were isolated by negative selec-
tion, as previously described (  35  ), depleting cells expressing CD8, CD11b, 
MHC class II, and NK1.1. For FACS isolation, negatively selected CD4  +   
T cells were stained with anti-CD4  –  PE  –  Cy5.5, anti-NK1.1  –  PE, and 
anti-CD25  –  FITC plus anti-CD44  –  allophycocyanin (BD) and sorted on a 
FACSAria (BD) by gating in the low forward scatter and low side scatter lym-
phocyte population. Antibodies against B220, CD19, IL-6R     (BD), and 
IL-21R (eBioscience) were also used for fl  ow cytometry. 
  CD4  +   T cells were activated with plate-bound 5   μ  g/ml anti-CD3 (2C11) 
and 1   μ  g/ml of soluble anti-CD28 (BD) mAbs in Bruff    ’  s medium in the pres-
ence or absence of diff  erent cytokines: 10 ng/ml TNF-    , 20 ng/ml IL-1    , 
50 U/ml IL-2, 10  3   U/ml IL-4, 100 ng/ml IL-6, 3.5 ng/ml IL-12, 10 ng/ml 
IFN-     (all obtained from R  &  D Systems), 100 ng/ml IL-11 (Genetics Institute), 
100 ng/ml IL-21 (PeproTech), or 10 ng/ml LPS (Sigma-Aldrich). 
  B cells were purifi  ed by positive selection using anti-CD19 MACS beads 
(Miltenyi Biotec) according to the manufacturer  ’  s instructions and were gen-
erally   >  95% CD19  +  B220  +  . For co-culture experiments, CD4  +   T cells were 
stimulated with 5   μ  g/ml of plate-bound anti-CD3 (2C11) and mixed with B 
cells in a 1:3 T/B cell ratio. 
  ELISAs 
  For IL-21 detection, the mouse-specifi  c IL-21 DuoSet kit was used according 
to the manufacturer  ’  s protocol (R  &  D Systems). IgG1 levels were determined 
with anti  –  mouse IgG1 as capture antibody and horseradish peroxidase (HRP)  –
  conjugated anti  –  mouse IgG1 as detection antibody, with mouse IgG1 as stan-
dard (all obtained from SouthernBiotech). Infl  uenza-specifi  c antibody isotypes 
were determined using UV-inactivated infl  uenza PR8 as antigen. Antibody 
levels in serially diluted serum samples were analyzed with HRP-conjugated 
antibodies specifi  c for mouse IgM, IgG1, and IgG2c (SouthernBiotech). 
  ELISPOT assay 
  IL-21  –  producing CD4  +   T cells were detected according to a protocol adapted 
from a previously published paper (  36  ). In brief, CD4  +   T cells were activated 
with anti-CD3 and anti-CD28 mAbs in the presence or absence of IL-6 or an 
anti  –  IL-6 mAb. After 45 h, cells were harvested and counted, and 10  4   cells per 
well were plated in anti  –  IL-21  –  coated ELISPOT plates. Cells were incubated 
for 4 h in medium alone or medium containing 5 ng/ml PMA and 250 ng/ml 
ionomycin. Plates were developed as previously described (  36  ) using a bio-
tinylated anti  –  IL-21 mAb, and the total number of IL-21  –  producing cells was 
determined in an ELISPOT reader (CTL-ImmunoSpot S5 ELISPOT reader; 
Cellular Technology Ltd.). 
  Analysis of RNA 
  Total RNA was extracted from cells by using the RNAeasy kit (QIAGEN) 
as recommended by the manufacturer. RNA was reverse transcribed into 
cDNA, as previously described (  37  ). mRNA levels were quantifi  ed with a 
the contribution of endogenous IL-21 to the production of 
virus-specifi  c antibodies in response to a sublethal dose (0.1 
LD  50  ) of the live PR8 infl  uenza virus using wild-type and 
IL-21  –  defi  cient mice. 14 d after infection, infl  uenza-specifi  c 
antibody titers in serum were determined. Infl  uenza-specifi  c 
IgG1 and IgG2c levels were severely reduced in infected 
IL-21      /      mice compared with wild-type mice (  Fig. 5 A  ).   
Thus, IL-21 plays a role in antibody response to infl  uenza. 
We also examined the contribution of endogenous IL-6 to 
the antibody production against infection with PR8 infection 
using IL-6      /      mice. Interestingly, we found in repeated ex-
periments that IL-6  –  defi  cient mice were highly susceptible 
to infl  uenza virus infection, because a sublethal dose of live 
PR8 was suffi   cient to cause a relatively high rate of mortality 
in these mice but not in wild-type mice (  Fig. 5 B  ), indicating 
that IL-6 is essential for protection against infl  uenza virus. 
Unlike infected wild-type mice, infected IL-6      /      mice could 
not recover the weight loss caused by the acute viral infection 
(  Fig. 5 C  ), suggesting that these mice could not clear or con-
trol     the virus. Analysis of PR8-specifi  c antibody production 
in the surviving IL-6      /      mice showed a reduction in virus 
antibody titers (  Fig. 5 D  ). IL-6 is therefore a key cytokine for 
resolution of infl  uenza virus infection. 
  In summary, we show that IL-6 is a very specifi  c and ef-
fective inducer of IL-21 production by CD4  +   T cells, and that 
it is suffi   cient and required for IL-21 production by naive (and 
probably memory) CD4  +   T cells upon antigen stimulation in 
vitro and in vivo  .   Although it was proposed that IL-21 is pref-
erentially expressed by eff  ector Th17 cells (  24, 27  –  29  ), a re-
cently published study (  23  ), as well as our results in this report, 
show that IL-6, in the absence of TGF-    , can induce the pro-
duction of IL-21 in CD4  +   T cells. IL-21 is also produced by 
the T follicular helper (Tfh) subset of CD4  +   T cells that local-
izes in B cell follicles and provides help to B cells (  31  ). Because 
follicular dendritic cells produce signifi  cant amounts of IL-6 
(  13  ), it is possible that the presence of IL-6 in follicles can 
contribute to the production of IL-21 by these Tfh cells. A 
study published at the time of submission of this manuscript 
supports the need of IL-6 for the generation of Tfh cells (  32  ). 
  Although IL-6 has been long considered as a B cell 
growth factor and mediator of plasma cell diff  erentiation, 
our data in this report show the requirement of IL-21 for 
IL-6 to induce antibody production in vitro and in vivo. We 
propose that IL-6 enhances antibody production indirectly 
by acting on naive (and likely memory) antigen-specifi  c 
CD4  +   T cells to promote their diff  erentiation into Tfh cells 
that produce high levels of IL-21. Accordingly, we also 
show that both IL-6 and IL-21 play a role in the immune 
response during infl  uenza infection, and administration of 
IL-6 during viral immunization substantially increased virus-
specifi  c antibody response without the need of additional 
coadjuvants, but in an IL-21  –  dependent manner. The use of 
IL-6 as coadjuvant during immunization may therefore be a 
promising tool to achieve successful vaccination against spe-
cifi  c pathogens whose clearance is highly dependent on hu-
moral immunity. JEM VOL. 206, January 19, 2009  77
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